Avesthagen Limited To Manufacture Bioactives For Ayurvedic Drugs

November 27th, 2008 by Vikas Sharma Leave a reply »

AVESTHAGEN LIMITED, India’s leading life sciences company that focuses on the convergence of food, pharma and population genetics leading to predictive, preventive, personalized healthcare has been granted a license to manufacture bioactives for Ayurvedic Drugs by the Drugs Licensing Authority, under the Department of AYUSH, Ministry of Health & Family Welfare, Government of India. This license will help Avesthagen to tap into the huge Indian Ayurvedic market and the growing global market of Ayurvedic products.

Dr. Villoo Morawala Patell, Founder, Chairman and Managing Director of AVESTHAGEN LIMITED said “This license is proof that our research & development activities are reaping results. This significant milestone has opened a large market for us offering a great opportunity for growth. Ayurveda is one of the oldest health care systems in India, and this is a great opportunity for us to popularize the system internationally.”

The Ayurvedic industry, recorded annual sales of about Rs 7,000 crore in fiscal 2008. Ayurvedic ingredients, have been used in Indian healthcare and cosmetics products for centuries, are becoming increasingly popular in the West as the trend for natural and more holistic products continues. According to market research analysts, Indian Ayurvedic firms have the potential to strike $120 Billion in the global Herbal Market, and also have the potential to export them.

AVESTHAGEN LIMITED’S bioactive manufacturing unit, Dhanvantari Botanicals Pvt. Ltd., located near Bangalore, India is an ISO 9001:2000 certified unit. It is also one of the first few bioactive manufacturing units across the world to achieve ISO 22000-2005 and “Certified Organic” for processing. This facility is spread over 50,000 square feet with a state-of-the-art production and a R&D facility. The herbal extract manufacturing unit is the first of its kind in Karnataka with a certification by the Indian System of Medicine and Homeopathy to manufacture 43 bioactives as Ayurvedic products.

This bioactive manufacturing unit adheres to very stringent quality control and quality assurance norms. The quality and food safety management systems at this unit ensure production of high quality botanical extracts at competitive prices. To ensure no slippage in manufacturing, the unit employs a very competitive staff.

Random Ayurveda News

  • Experts to consider ways to improve medical education (0)
    The annual day function of the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), was organised in the varsity on Wednesday. The function was a part of golden jubilee celebrations of establishment of the medical institute. The even...
  • Ayurveda ban in EU, bitter pill for state (0)
    With barely a month to go before Ayurveda drugs go off the shelves across European Union, which has imposed a ban from May 1, the Rs.600-crore Ayurveda industry in Kerala, home to the traditional medical system, remains rattled and unprepared to face...
  • The Chopra Foundation Hosts High-Profile “Sages and Scientists Symposium” to Support Humanitarian Causes (0)
    Created as a dynamic forum for the world's most innovative thinkers and doers, the Sages and Scientists Symposium will take place this February 25-27 at La Costa Resort and Spa in Carlsbad, CA. "The Chopra Foundation created the Sages and Scientists...
  • Baba Ramdev speaks against Genetically Modified seeds (0)
    Hospet:  Baba Ramdev, the world-renowned yoga guru has expressed his deep concern and opposition to Genetically Modified (GM) food crops. Addressing journalists  at a press conference in Hospet on the eve of a week-long yoga camp, the Yoga Guru used ...
Advertisement

Leave a Reply